These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments

The lucrative market for weight loss drugs won’t stay a duopoly forever. With billions at stake,…

Why half of all workers may struggle to get weight-loss drug health insurance coverage

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City…

Nutritional needs are ‘shifting’ amid rise of weight loss drugs, says Nestle CEO

The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides new…

Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts

As new weight loss medications garnered buzz last year, analysts’ forecasts signaled these drugs would be…

This under-the-radar biotech could be the next way to play the obesity drug boom

The lucrative market for obesity drugs is dominated by two players right now, but Structure Therapeutics…

Newseum Global